Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$423M |
| 2 |
Mettler-Toledo International
MTD
|
+$421M |
| 3 |
Capital One
COF
|
+$383M |
| 4 |
L3Harris
LHX
|
+$325M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.83B |
| 2 |
Microsoft
MSFT
|
+$1.62B |
| 3 |
Apple
AAPL
|
+$1.56B |
| 4 |
NVIDIA
NVDA
|
+$1.36B |
| 5 |
Costco
COST
|
+$731M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.97% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 9.87% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Theravance Biopharma
TBPH
$881M
| $1.22M | ﹤0.01% |
110,546
-6,953
| -6% | -$67.6K |
|
|
TXUE
3002
Thornburg International Equity ETF
TXUE
$552M
| $1.22M | ﹤0.01% |
41,251
+12,958
| +46% | +$360K |
|
|
KALV
3003
DELISTED
KalVista Pharmaceuticals
KALV
| $1.22M | ﹤0.01% |
107,635
+4,105
| +4% | +$50.2K |
|
3004
OptimizeRx
OPRX
$164M
| $1.21M | ﹤0.01% |
89,777
+239
| +0.3% | +$2.61K |
|
3005
State Street Multi-Asset Real Return ETF
RLY
$1.31B
| $1.21M | ﹤0.01% |
41,627
+21,215
| +104% | +$602K |
|
3006
iShares Global Healthcare ETF
IXJ
$4.2B
| $1.21M | ﹤0.01% |
14,020
+1,493
| +12% | +$128K |
|
3007
First Trust Nasdaq Bank ETF
FTXO
$322M
| $1.21M | ﹤0.01% |
36,500
-623
| -2% | -$18.8K |
|
|
NBIS
3008
Nebius Group N.V.
NBIS
$75.5B
| $1.21M | ﹤0.01% |
21,788
-93
| -0.4% | -$3.2K |
|
|
SEMR
3009
DELISTED
Semrush
SEMR
| $1.21M | ﹤0.01% |
133,174
+19,995
| +18% | +$194K |
|
3010
Abeona Therapeutics
ABEO
$343M
| $1.21M | ﹤0.01% |
212,179
+90,727
| +75% | +$516K |
|
3011
Medallion Financial
MFIN
$264M
| $1.2M | ﹤0.01% |
126,038
-587
| -0.5% | -$5.32K |
|
3012
Costamare
CMRE
$1.77B
| $1.2M | ﹤0.01% |
131,773
+9,124
| +7% | +$81.2K |
|
3013
Hippo Holdings
HIPO
$872M
| $1.19M | ﹤0.01% |
42,649
-3,763
| -8% | -$92.7K |
|
3014
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
| $1.19M | ﹤0.01% |
8,858
-747
| -8% | -$92.1K |
|
3015
Aspen Aerogels
ASPN
$485M
| $1.19M | ﹤0.01% |
200,990
+12,424
| +7% | +$71.5K |
|
3016
LSB Industries
LXU
$737M
| $1.19M | ﹤0.01% |
152,322
+3,115
| +2% | +$21.3K |
|
3017
Atlanta Braves Holdings Series A
BATRA
$3.68B
| $1.19M | ﹤0.01% |
24,116
-2,929
| -11% | -$130K |
|
3018
Vishay Precision Group
VPG
$969M
| $1.18M | ﹤0.01% |
42,149
+1,178
| +3% | +$29K |
|
3019
Aehr Test Systems
AEHR
$4.37B
| $1.18M | ﹤0.01% |
91,566
+2,714
| +3% | +$25.8K |
|
3020
Regenxbio
RGNX
$711M
| $1.18M | ﹤0.01% |
144,110
+2,710
| +2% | +$22.7K |
|
3021
ClearPoint Neuro
CLPT
$468M
| $1.18M | ﹤0.01% |
+98,961
| New | +$1.25M |
|
3022
Nabors Industries
NBR
$1.39B
| $1.18M | ﹤0.01% |
42,166
+12,790
| +44% | +$381K |
|
3023
Ericsson
ERIC
$33.6B
| $1.18M | ﹤0.01% |
139,272
-704
| -0.5% | -$5.79K |
|
3024
Puma Biotechnology
PBYI
$456M
| $1.18M | ﹤0.01% |
344,083
+3,197
| +0.9% | +$10.2K |
|
3025
Bank7 Corp
BSVN
$498M
| $1.18M | ﹤0.01% |
28,205
+1,405
| +5% | +$53.3K |
|
Similar funds
Bank of New York Mellon's Q2 2025 Portfolio in Review
As of Q2 2025, Bank of New York Mellon held 4,353 positions worth $529B, up 4.8% from $505B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon withdrew a net $22.6B in Q2 2025, closing 217 positions and reducing 1,932 holdings. Its most notable exit was Discover Financial Services, an estimated $274M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bank of New York Mellon opened a new position in JPMorgan Hedged Equity Laddered Overlay ETF worth $93.7M.
- Bank of New York Mellon's largest Q2 2025 buy was JPMorgan Hedged Equity Laddered Overlay ETF: 1,498,016 shares worth $93.7M.
- Bank of New York Mellon added most to Idexx Laboratories in Q2 2025, an estimated $423M increase.
- Bank of New York Mellon's biggest Q2 2025 reduction was Alphabet (Google) Class C, cutting an estimated $1.83B.
- Bank of New York Mellon fully exited Discover Financial Services in Q2 2025, selling an estimated $274M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $529B portfolio in Q2 2025.
- Bank of New York Mellon opened 243 new positions and closed 217 in Q2 2025.
- Bank of New York Mellon's portfolio value rose 4.8% quarter-over-quarter to $529B.
Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.